Simon Herrington
Professor of Molecular Cancer Pathology
- Cancer Research UK Edinburgh Centre
- MRC Institute of Genetics & Cancer
Contact details
- Tel: +44 (0)131 651 8690
- Email: Simon.Herrington@ed.ac.uk
Address
- Street
-
Cancer Research UK Edinburgh Centre
MRC Institute of Genetics & Cancer
The University of Edinburgh
Western General Hospital
Crewe Road South - City
- Edinburgh
- Post code
- EH4 2XR
Background
Simon Herrington graduated in biochemistry with honours from the University of Cambridge in 1982 and medicine with honours from the University of London in 1985. He trained in Internal Medicine (MRCP 1988) and then became a CRC clinical research fellow in the Nuffield Department of Pathology, University of Oxford, receiving his DPhil in 1991. He was appointed clinical lecturer in pathology in Oxford where he completed his training in clinical cellular pathology, gaining the MRCPath in 1994. He was appointed clinical senior lecturer and consultant in pathology at the University of Liverpool in 1995 and was promoted to a Personal Chair in 1999. In 2003, he was appointed to the Chair of Pathology at the University of St Andrews, moving to the Chair of Pathology at the University of Dundee in 2010 and the Chair of Molecular Cancer Pathology at the University of Edinburgh in 2015. He also works as a consultant pathologist, specialising in gynaecological pathology, was co-editor of the 4th and 5th Editions of the WHO Classification of Tumours of Female Reproductive Organs and edited the 15th and 16th Editions of Muir’s Textbook of Pathology. He is a past President of the International Society of Gynecological Pathologists, and is Editor in Chief of the Journal of Pathology and the Journal of Pathology: Clinical Research.
-
Debiased ambient vibrations optical coherence elastography to profile cell, organoid and tissue mechanical properties
In:
Communications biology
DOI: https://doi.org/10.1038/s42003-023-04788-0
Research output: Contribution to Journal › Article (E-pub ahead of print) -
Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome
In:
Gynecologic Oncology
Research output: Contribution to Journal › Article (Published) -
Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma
In:
Scientific Reports
DOI: https://doi.org/10.1038/s41598-023-34627-5
Research output: Contribution to Journal › Article (Published) -
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
In:
The Lancet Oncology, vol. 23, pp. e374-e384
DOI: https://doi.org/10.1016/S1470-2045(22)00139-5
Research output: Contribution to Journal › Article (Published) -
Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high grade serous
In:
British Journal of Cancer
DOI: https://doi.org/10.1038/s41416-022-01874-8
Research output: Contribution to Journal › Article (E-pub ahead of print)